New Data Presented at the 2023 ATA Annual Meeting Demonstrate that Veracyte's Afirma-Based Testing Can Uncover Key Molecular Hallmarks of Thyroid Cancer
Company also introduces research-use-only Afirma Genomic Resource for Intelligent Discovery platform for additional insights into thyroid nodules and cancer ...
Source: marketscreener.com